Claims
- 1. A bi-aromatic ester having the formula ##STR13## wherein R.sub.1 represents --COOR.sub.9,
- R.sub.9 represents hydrogen, alkyl having 1-6 carbon atoms, monohydroxyalkyl or polyhydroxyalkyl,
- R.sub.2 represents hydrogen, alkyl having 1-6 carbon atoms, OR.sub.9, fluorine or --CF.sub.3,
- R.sub.3, R.sub.4 and R.sub.5 represent hydrogen, fluorine, OH, --CH.sub.3, --OCH.sub.3 --CH.sub.3, --COOH or --CH.sub.2 OH,
- R.sub.6 and R.sub.8 represent hydrogen, .alpha.-substituted alkyl having 3-15 carbon atoms, .alpha.,.alpha.'-disubstituted alkyl having 4-12 carbon atoms, cycloalkyl having 3-12 carbon atoms, mono- or polycyclic cycloalkyl having 5-12 carbon atoms whose linking carbon is trisubstituted, --SR.sub.11, --SO.sub.2 R.sub.11 or --SOR.sub.11,
- R.sub.11 represents alkyl having 1-6 carbon atoms or cycloalkyl, with the proviso that R.sub.6 and R.sub.8 do not simultaneously represent hydrogen,
- R.sub.7 represents OR.sub.12, SR.sub.13, SOR.sub.14 or SO.sub.2 R.sub.14,
- R.sub.12 is monohydroxyalkyl, polyhydroxyalkyl or --(CH.sub.2).sub.n --COR.sub.15, wherein n is 0.1 or 2, and R.sub.15 represents hydrogen, OH, alkyl having 1-6 carbon atoms or alkoxy having 1-6 carbon atoms,
- R.sub.13 represents hydrogen, alkyl having 1-6 carbon atoms or aralkyl,
- R.sub.14 represent OH, alkyl having 1-6 carbon atoms or aralkyl,
- with the proviso that when R.sub.2 represents hydrogen then:
- (i) either R.sub.3 and R.sub.4 are other than hydrogen or --CH.sub.3,
- (ii) or R.sub.7 is other than OR.sub.12 and R.sub.6 or R.sub.8 is cycloalkyl having more than 7 carbon atoms,
- (iii) or R.sub.7 represents OR.sub.12, but R.sub.6 or R.sub.8 is other than hydrogen,
- (iv) or R.sub.7 represents OR.sub.12 but R.sub.5 is other than hydrogen.
- 2. The compound of claim 1 selected from the group consisting of
- 4-[3-(1-adamantyl)-4-methylthiobenzoyloxy] benzoic acid,
- 4-[3-(1-adamantyl)-4-acetoxybenzoyloxy] benzoic acid,
- 4-[3-(1-adamantyl)-4-methylsulfonebenzoyloxy] benzoic acid,
- 4-[3-(1-adamantyl)-4-(carboxy methyleneoxy) benzoyloxy] benzoic acid,
- 4-[3-(1-adamantyl)-4-(2,3-dihydroxypropyloxy) benzoyloxy] benzoic acid and
- 4-[3-(1-adamantyl)-4-methoxycarbonylmethyloxy] benzoic acid.
- 3. A pharmaceutical composition comprising in a pharmaceutically acceptable vehicle suitable for enteral, parenteral, topical or ocular administration to an animal or man, at least one compound of formula (I) of claim 1.
- 4. The composition of claim 3 wherein said compound of formula (I) is present in an amount ranging from 0.0001 to about 5 percent by weight based on the total weight of said composition.
- 5. A method for the treatment of a dermatologic, rheumatismal, respiratory or ophthalmologic ailment comprising administering to an animal or a person suffering from said ailment an effective amount of the composition of claim 3.
- 6. A cosmetic composition for body and hair hygiene comprising in a cosmetically acceptable vehicle at least one compound of formula (I) of claim 1.
- 7. The composition of claim 6 wherein said compound of formula (I) is present in an amount ranging from 0.0001 to 1 percent by weight based on the total weight of said composition.
- 8. 4-[3-(1-adamantyl)-4-methylthiobenzoyloxy] benzoic acid.
Priority Claims (1)
| Number |
Date |
Country |
Kind |
| 89 09652 |
Jul 1989 |
FRX |
|
Parent Case Info
This is a division of application Ser. No. 07/553,087, filed Jul. 17, 1990 now U.S. Pat. No. 5,200,550.
US Referenced Citations (1)
| Number |
Name |
Date |
Kind |
|
4000144 |
Haas et al. |
Dec 1976 |
|
Foreign Referenced Citations (1)
| Number |
Date |
Country |
| 0232199 |
Aug 1987 |
EPX |
Divisions (1)
|
Number |
Date |
Country |
| Parent |
553087 |
Jul 1990 |
|